GSK2606414

CHF 108.00
In stock
SYN-1201-M0011 mgCHF 108.00
SYN-1201-M0055 mgCHF 192.00
SYN-1201-M01010 mgCHF 299.00
SYN-1201-M05050 mgCHF 826.00
SYN-1201-M100100 mgCHF 1'185.00
 
More Information
Product Details
Synonyms GSK-2606414
Product Type Chemical
Properties
Formula C24H20F3N5O
MW 451.4
CAS 1337531-36-8
Purity Chemicals ≥95%
Appearance Solid.
Solubility Soluble in DMSO or ethanol.
Declaration Manufactured by SynKinase.
Other Product Data Target: PERK | Kinase Group: Other | Substrate: Serine-Threonine

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.
InChi Key SIXVRXARNAVBTC-UHFFFAOYSA-N
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
GSK2606414 is an orally available, potent, and selective PERK inhibitor with IC(50) of 0.4nM, displaying at least 100-fold selectivity over the other EIF2AKs assayed.
Product References
  1. Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK): J.M. Axten, et al.; J. Med. Chem. 55, 7193 (2012)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.